Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Baylor College of Medicine
Chimeric influenza HA/SHIV virus-like particles show promise for mucosal immunization
July 30th, 2003
by Michael Greer, senior medical writer - Researchers in Texas have developed a novel technique for mucosal immunization against HIV infection. "To enhance mucosal immune responses using simian-human immunodeficiency virus-like particles (SHIV VLPs) as a mucosal HIV vaccine," Qizhi Yao and colleagues at Baylor College of Medicine in Houston "produced phenotypically mixed, chimeric influenza HA/SHIV 89.6 VLPs and used them to immunize C57B/6J mice intranasally." Humoral and cellular mucosal immune activity induced by chimeric VLPs was significantly more robust than that elicited by unmodified SHIV particles, Yao and coauthors found. ...
Source: Biotech Week (2003-07-30)
|
